Lupin enters prescription dermatology segment in Brazil Ruby Khatun Khatun27 Aug 2018 10:15 AM ISTNew Delhi: Drug maker Lupin said it has entered the prescription dermatology segment in Brazil with the launch of two products Fillerina and Recrexina...
FDA approves Shire drug for rare swelling disorder Ruby Khatun Khatun27 Aug 2018 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved a first of its kind drug from Shire Plc to treat patients aged 12 and older suffering from a rare...
Novartis trial win lifts profile of new breast cancer drug Ruby Khatun Khatun27 Aug 2018 9:30 AM ISTZURICH: Novartis's efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded, as the Swiss drugmaker said one of...
Lupin gets USFDA tentative approval for generic Nudovra Ruby Khatun Khatun26 Aug 2018 11:00 AM ISTMumbai: Pharma major Lupin announced that it has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol...
CEO’s of Novartis, WhatsApp meet Telangana Minister Ruby Khatun Khatun26 Aug 2018 10:15 AM ISTHyderabad: Two eminent corporate honchos- CEO of Whatsapp and Novartis, separately met the Telangana Minister for IT and Industries KT Rama Rao...
AstraZeneca inhaler lags GSK drug in lung disease trial Ruby Khatun Khatun26 Aug 2018 10:00 AM ISTLONDON: A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result...
USFDA approves Kala Pharma's eye pain drug Ruby Khatun Khatun26 Aug 2018 9:45 AM ISTThe U.S. Food and Drug Administration approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.The...
AbbVie doubles down on cancer project with biotech group Argenx Medical Dialogues Bureau26 Aug 2018 9:30 AM ISTBRUSSELS: Biotech group Argenx said U.S. pharma group AbbVie had exercised an exclusive option to develop and commercialize one of its experimental...
Lupin gets EIR from USFDA for Nagpur facility Ruby Khatun Khatun25 Aug 2018 11:12 AM ISTNew Delhi: Drug firm Lupin said it has received an establishment inspection report (EIR) from the US health regulator after the successful inspection...
FDA approves Oxervate for neurotrophic keratitis, a rare eye disease Ruby Khatun Khatun25 Aug 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare...
Focus on 20 key brands to drive growth: GSK Pharma Medical Dialogues Bureau25 Aug 2018 10:00 AM ISTNew Delhi: Drug firm Glaxo Smith Kline Pharmaceuticals said it has decided to concentrate on 20 key brands to drive growth going forward."In keeping...
Oklahoma Medicaid tests new tactic to curb US drug costs Ruby Khatun Khatun25 Aug 2018 9:45 AM ISTLOS ANGELES: A new front in the battle over the cost of expensive medicines in the United States is opening up in Oklahoma, the first state where the...
